
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
circCDYL2 promotes trastuzumab resistance via sustaining HER2 downstream signaling in breast cancer
Yun Ling, Gehao Liang, Qun Lin, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 64
Yun Ling, Gehao Liang, Qun Lin, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 64
Showing 1-25 of 64 citing articles:
Circular RNAs in breast cancer diagnosis, treatment and prognosis
X. Huang, CAILU SONG, JINHUI ZHANG, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2023) Vol. 32, Iss. 2, pp. 241-249
Open Access | Times Cited: 56
X. Huang, CAILU SONG, JINHUI ZHANG, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2023) Vol. 32, Iss. 2, pp. 241-249
Open Access | Times Cited: 56
New insight into circRNAs: characterization, strategies, and biomedical applications
Xin-Yi Feng, Shun-Xin Zhu, Ke‐Jia Pu, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 46
Xin-Yi Feng, Shun-Xin Zhu, Ke‐Jia Pu, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 46
Roles and inhibitors of FAK in cancer: current advances and future directions
Hui-Hui Hu, Saiqi Wang, Hai-Li Shang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 24
Hui-Hui Hu, Saiqi Wang, Hai-Li Shang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 24
Progress in the studies on the molecular mechanisms associated with multidrug resistance in cancers
Lei Zhang, Biwei Ye, Zhuo Chen, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 3, pp. 982-997
Open Access | Times Cited: 55
Lei Zhang, Biwei Ye, Zhuo Chen, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 3, pp. 982-997
Open Access | Times Cited: 55
Circular RNA-mediated miRNA sponge & RNA binding protein in biological modulation of breast cancer
Jing Zhu, Qian Li, Zhongping Wu, et al.
Non-coding RNA Research (2024) Vol. 9, Iss. 1, pp. 262-276
Open Access | Times Cited: 10
Jing Zhu, Qian Li, Zhongping Wu, et al.
Non-coding RNA Research (2024) Vol. 9, Iss. 1, pp. 262-276
Open Access | Times Cited: 10
The roles and molecular mechanisms of non-coding RNA in cancer metabolic reprogramming
Shizhen Li, Mingjing Peng, Shiming Tan, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 9
Shizhen Li, Mingjing Peng, Shiming Tan, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 9
Mechanisms and therapeutic implications of gene expression regulation by circRNA-protein interactions in cancer
Nan Zhang, Xinjia Wang, Yu Li, et al.
Communications Biology (2025) Vol. 8, Iss. 1
Open Access | Times Cited: 1
Nan Zhang, Xinjia Wang, Yu Li, et al.
Communications Biology (2025) Vol. 8, Iss. 1
Open Access | Times Cited: 1
A comprehensive exploration of adverse reactions to lapatinib: a disproportionate analysis based on the FAERS database
Yao Zhou, Jie Gong, Xianguang Deng, et al.
Expert Opinion on Drug Safety (2025)
Closed Access | Times Cited: 1
Yao Zhou, Jie Gong, Xianguang Deng, et al.
Expert Opinion on Drug Safety (2025)
Closed Access | Times Cited: 1
CircIPO7 Promotes Nasopharyngeal Carcinoma Metastasis and Cisplatin Chemoresistance by Facilitating YBX1 Nuclear Localization
Xiao-Hong Hong, Qian Li, Jun-Yan Li, et al.
Clinical Cancer Research (2022) Vol. 28, Iss. 20, pp. 4521-4535
Open Access | Times Cited: 34
Xiao-Hong Hong, Qian Li, Jun-Yan Li, et al.
Clinical Cancer Research (2022) Vol. 28, Iss. 20, pp. 4521-4535
Open Access | Times Cited: 34
MIL-125-based nanocarrier decorated with Palladium complex for targeted drug delivery
Mojtaba Bagherzadeh, Moein Safarkhani, Mahsa Kiani, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 32
Mojtaba Bagherzadeh, Moein Safarkhani, Mahsa Kiani, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 32
Interactions between circRNA and protein in breast cancer
Bin Yang, Ya‐Wen Wang, Kai Zhang
Gene (2023) Vol. 895, pp. 148019-148019
Closed Access | Times Cited: 17
Bin Yang, Ya‐Wen Wang, Kai Zhang
Gene (2023) Vol. 895, pp. 148019-148019
Closed Access | Times Cited: 17
CircCDYL2 bolsters radiotherapy resistance in nasopharyngeal carcinoma by promoting RAD51 translation initiation for enhanced homologous recombination repair
Hongke Qu, Yumin Wang, Qijia Yan, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 7
Hongke Qu, Yumin Wang, Qijia Yan, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 7
In silico Analysis and Comprehensive Review of Circular-RNA Regulatory Roles in Breast Diseases; a Step-Toward non-coding RNA Precision
Nadia Μ. Hamdy, Mona G. El-Sisi, Sherine M. Ibrahim, et al.
Pathology - Research and Practice (2024) Vol. 263, pp. 155651-155651
Closed Access | Times Cited: 6
Nadia Μ. Hamdy, Mona G. El-Sisi, Sherine M. Ibrahim, et al.
Pathology - Research and Practice (2024) Vol. 263, pp. 155651-155651
Closed Access | Times Cited: 6
EIF4A3-mediated circ_0042881 activates the RAS pathway via miR-217/SOS1 axis to facilitate breast cancer progression
Chenxi Ju, Mingxia Zhou, Dan Du, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 8
Open Access | Times Cited: 15
Chenxi Ju, Mingxia Zhou, Dan Du, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 8
Open Access | Times Cited: 15
Circular RNAs: biology and clinical significance of breast cancer
Zhanwei Wang, Hao Deng, Jin Yao, et al.
RNA Biology (2023) Vol. 20, Iss. 1, pp. 859-874
Open Access | Times Cited: 15
Zhanwei Wang, Hao Deng, Jin Yao, et al.
RNA Biology (2023) Vol. 20, Iss. 1, pp. 859-874
Open Access | Times Cited: 15
TRIM36 Inhibits the Development of AOM/DSS‐Induced Colitis‐Associated Colorectal Cancer by Promoting the Ubiquitination and Degradation of GRB7
Wu Ju, Zhengbo Yang, Xi Chen, et al.
Molecular Carcinogenesis (2025)
Closed Access
Wu Ju, Zhengbo Yang, Xi Chen, et al.
Molecular Carcinogenesis (2025)
Closed Access
Mesenchymal Stem Cell-Derived Exosomes in Cancer Resistance Against Therapeutics
Vignesh Balaji E, Keerthilatha M. Pai, K. Sreedhara Ranganath Pai
Cancers (2025) Vol. 17, Iss. 5, pp. 831-831
Open Access
Vignesh Balaji E, Keerthilatha M. Pai, K. Sreedhara Ranganath Pai
Cancers (2025) Vol. 17, Iss. 5, pp. 831-831
Open Access
CircRNAs regulate the crosstalk between inflammation and tumorigenesis: The bilateral association and molecular mechanisms
Javeria Qadir, Shuo‐Yang Wen, Hui Yuan, et al.
Molecular Therapy (2022) Vol. 31, Iss. 6, pp. 1514-1532
Open Access | Times Cited: 20
Javeria Qadir, Shuo‐Yang Wen, Hui Yuan, et al.
Molecular Therapy (2022) Vol. 31, Iss. 6, pp. 1514-1532
Open Access | Times Cited: 20
Emerging insights into mechanisms of trastuzumab resistance in HER2-positive cancers
Xiaoxue Wu, Shuting Huang, Weiling He, et al.
International Immunopharmacology (2023) Vol. 122, pp. 110602-110602
Closed Access | Times Cited: 11
Xiaoxue Wu, Shuting Huang, Weiling He, et al.
International Immunopharmacology (2023) Vol. 122, pp. 110602-110602
Closed Access | Times Cited: 11
Non-coding RNAs’ function in cancer development, diagnosis and therapy
Xinyi Zhang, Xiaoqing Xu, Jiajia Song, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115527-115527
Open Access | Times Cited: 11
Xinyi Zhang, Xiaoqing Xu, Jiajia Song, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115527-115527
Open Access | Times Cited: 11
CircRNA circRREB1 promotes tumorigenesis and progression of breast cancer by activating Erk1/2 signaling through interacting with GNB4
Hong Chen, Xiaosong Wang, Hang Cheng, et al.
Heliyon (2024) Vol. 10, Iss. 7, pp. e28785-e28785
Open Access | Times Cited: 4
Hong Chen, Xiaosong Wang, Hang Cheng, et al.
Heliyon (2024) Vol. 10, Iss. 7, pp. e28785-e28785
Open Access | Times Cited: 4
mRNA-based therapeutic strategies for cancer treatment
Thilelli Taibi, Sehyun Cheon, Fabiana Perna, et al.
Molecular Therapy (2024) Vol. 32, Iss. 9, pp. 2819-2834
Closed Access | Times Cited: 4
Thilelli Taibi, Sehyun Cheon, Fabiana Perna, et al.
Molecular Therapy (2024) Vol. 32, Iss. 9, pp. 2819-2834
Closed Access | Times Cited: 4
From diagnosis to therapy: The role of LncRNA GAS5 in combatting some cancers affecting women
Chou‐Yi Hsu, Safia Obaidur Rab, Ahmed Hussein Zwamel, et al.
Gene (2025), pp. 149217-149217
Closed Access
Chou‐Yi Hsu, Safia Obaidur Rab, Ahmed Hussein Zwamel, et al.
Gene (2025), pp. 149217-149217
Closed Access
Circular RNAs in cancer
Yang Guo, Qiang Huang, Heng Yu, et al.
MedComm (2025) Vol. 6, Iss. 2
Open Access
Yang Guo, Qiang Huang, Heng Yu, et al.
MedComm (2025) Vol. 6, Iss. 2
Open Access
ALKBH1-mediated N6-methyladenosine methylation of TRAF1 promotes osteosarcoma proliferation and metastasis
Zhichao Wang, Yu Fang, Yang Yu, et al.
American Journal of Cancer Research (2025) Vol. 15, Iss. 1, pp. 375-389
Closed Access
Zhichao Wang, Yu Fang, Yang Yu, et al.
American Journal of Cancer Research (2025) Vol. 15, Iss. 1, pp. 375-389
Closed Access